Ironwood Pharmaceuticals, Inc.
IRWD · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $296M | $351M | −15.7% |
| Operating income | $98.5M | $93.1M | +5.8% |
| Net income | $24.0M | $880K | +2,630% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $133M | $122M | +8.9% |
| Operating income | $93.1M | $75.5M | +23.3% |
| Net income | $59.8M | $40.1M | +49.1% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Ironwood's revenue in FY2025?
- $296M in FY2025 (Fiscal year ended Dec 31, 2025), −15.7% vs $351M a year earlier, per its 10-K filed Feb 2026.
- Was Ironwood profitable in FY2025?
- Yes: net income was $24.0M and operating income $98.5M in FY2025.
- What was Ironwood's revenue in Q3 2026?
- $133M (+8.9% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.